Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Profit After TaxShare-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Innate Pharma (IPHA) Income from Continuing Operations (2021)

Historic Income from Continuing Operations for Innate Pharma (IPHA) over the last 1 years, with Q4 2021 value amounting to -$54.7 million.